VASCERN News
23 July 2024
Revision of Rare Vascular Tumors in the Orphanet Database
A new collaborative research publication has been published in the JAMA by Dr. Sophie Dupuis-Girod, Co-chair of the VASCern HHT-WG and HCP Representative of the French HHT Reference Center, Hospices Civils de Lyon:
Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia: A Randomized Clinical Trial | Sep 06, 2016 | JAMA | JAMA Network